Biotech

All Articles

8 months after a $213M fundraise, gene publisher Volume makes cuts

.After raising $213 thousand in 2023-- some of the year's most extensive personal biotech rounds-- V...

BioMarin creates exec team with biotech vets-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings ...

Biopharma Q2 VC reached highest degree given that '22, while M&ampA slowed down

.Equity capital funding into biopharma cheered $9.2 billion across 215 handle the 2nd fourth of this...

Bicara, Zenas look for IPOs to push late-phase assets towards market

.Bicara Therapies and Zenas Biopharma have offered fresh motivation to the IPO market with filings t...

Genentech to finalize cancer cells immunology study division

.Genentech is going to close its cancer cells immunology research study department, and also device ...

Kezar loses sound cyst yet to confirm its own truly worth in phase 1 trial

.Kezar Life Sciences is actually dropping its unpromising period 1 solid lump medicine as the biotec...

Acelyrin drops izokibep, lets go 3rd of personnel

.Regardless of izokibep keeping its own newly found winning touch in the center, Acelyrin is actuall...

Rivus' phase 2 obesity-related heart failure test hits endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its own fat-busting, muscle-sparing...

Ovid stops preclinical work, IV program after soticlestat stop working

.Ovid Therapeutics already uncovered last month that it was trimming its own head count as the firm ...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has actually opened a $700 thousand R&ampD facility in the Boston Port, boosting its RNA ...